136
Participants
Start Date
October 31, 2009
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
New Genotropin Pen
Subjects will use the genotropin pen for 2 months. After 2 months patients and caregiver will be asked to fill out a questionnaire to assess perception of the genotropin pen
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Florence
Pfizer Investigational Site, Tallahassee
Pfizer Investigational Site, Gainesville
Pfizer Investigational Site, Gainesville
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Southaven
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Akron
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Kansas City
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Fort Worth
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Greenwood Village
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Morristown
Lead Sponsor
Pfizer
INDUSTRY